Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.

Rationale \| Elective neck irradiation is performed in head and neck cancer patients treated with definitive (chemo)radiotherapy. The aim is to eradicate nodal metastases that are not detectable by pretreatment imaging techniques. It is conceivable that personalized neck irradiation can be performed guided by the results of sentinel lymph node biopsy. It is expected that elective neck irradiation can be omitted to one or both sides of the neck in 9 out of 10 patients with a clinically negative neck (cN0). For patients with clinically positive ipsilateral nodes (cN1-2b), it is expected that ele

Trial Details

NCT ID
NCT05333523
Phase
PHASE3
Sponsor
Radboud University Medical Center
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • Sentinel lymph node biopsy guided selective elective neck irradiation
  • Standard elective neck irradiation
Locations (sample)
  • Amsterdam, Netherlands|52.37403,4.88969
  • Arnhem, Netherlands|51.98,5.91111
  • Enschede, Netherlands|52.21833,6.89583
  • Groningen, Netherlands|53.21917,6.56667
  • Leiden, Netherlands|52.15833,4.49306

Key Eligibility Criteria

  • Adult patients (≥18 years) with newly diagnosed cT1-4N0-2bM0 squamous cell carcinoma of the oropharynx (HPV-), larynx or hypopharynx, or cT1-4N0-1M…
  • Histopathological diagnosis of squamous cell carcinoma.
  • Adequate staging of the neck including CT or MRI, and 18F-FDG-PET demonstrating no contralateral lymph node metastases.
  • Recommendation for curative intent external beam (chemo)radiotherapy made by a multidisciplinary head and neck oncology team (in case of chemoradio…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →